Summary
The AI claims provided are largely non-label content (availability, pricing, coupons, PBMs, discount cards) that are not addressed in the supplied FDA label excerpts, and only a few general medical indication statements are provided without matching the label’s specific indication language and conditions (interdigital tinea pedis and specific organisms). No dosing, contraindications, boxed warnings, precautions details, or administration instructions matching the label were included.
Category Scores
Accurate Statements
Naftifine is an antifungal cream used to treat skin infections.
Only partially supported: the label excerpt states NAFTIN® Gel is an allylamine antifungal; it is indicated for interdigital tinea pedis. The claim is non-specific about the exact condition.
Unsupported Statements
Naftifine is used to treat athlete’s foot.
The label excerpt specifies interdigital tinea pedis due to specific organisms (Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum). The claim is overly general and does not include interdigital location or the specified organisms.
Naftifine is used to treat ringworm.
The provided label excerpt does not mention ringworm; it specifies interdigital tinea pedis caused by specific dermatophytes.
A generic version of Naftifine is available in most major pharmacy chains.
Not supported by the provided FDA label excerpts (label excerpts contain no statements about retail availability).
Generic Naftifine is often sold as a 1% or 2% cream.
The provided label excerpt specifies NAFTIN® Gel, 2% (gel formulation). No 1% cream is referenced in the supplied excerpts.
Generic formulations of Naftifine are usually priced 20–30% lower than the brand name product.
Not supported by the provided FDA label excerpts (no pricing/percent differences).
The FDA Generic Drug Database can confirm availability and standard strength options for generic Naftifine.
Not supported by the provided FDA label excerpts.
The original manufacturer occasionally releases coupons for Naftifine.
Not supported by the provided FDA label excerpts.
Naftifine coupons typically apply to a single purchase.
Not supported by the provided FDA label excerpts.
Naftifine coupons can reduce the price by a few dollars.
Not supported by the provided FDA label excerpts.
Coupons are usually available on the company’s website or through third-party coupon aggregators that specialize in prescription savings.
Not supported by the provided FDA label excerpts.
If health insurance covers topical antifungals, a pharmacy benefit manager (PBM) may negotiate a lower co-pay or provide an electronic discount code automatically at checkout.
Not supported by the provided FDA label excerpts.
A pharmacy benefit manager (PBM) may provide an electronic discount code automatically at checkout for Naftifine when covered.
Not supported by the provided FDA label excerpts.
Some nonprofits and patient-assistance programs offer free or discounted medication to those who meet income criteria.
Not supported by the provided FDA label excerpts.
Online discount cards and coupon sites such as GoodRx, RxSaver, and Blink Health collect price-matching data from multiple pharmacies.
Not supported by the provided FDA label excerpts.
GoodRx, RxSaver, and Blink Health often display the lowest available price for Naftifine and provide printable discount cards.
Not supported by the provided FDA label excerpts.
Using a discount card can reduce the retail price of Naftifine by 10–25%.
Not supported by the provided FDA label excerpts.
Generic 1% Naftifine cream (30 g) is $10–$15 at a brick-and-mortar pharmacy.
Not supported by the provided FDA label excerpts, and the supplied label excerpt describes a 2% gel formulation rather than 1% cream.
Generic 1% Naftifine cream (30 g) is $8–$12 online through price-matching sites.
Not supported by the provided FDA label excerpts, and the supplied label excerpt describes a 2% gel formulation rather than 1% cream.
Brand-name 1% Naftifine cream (30 g) is $18–$25.
Not supported by the provided FDA label excerpts, and the supplied label excerpt describes NAFTIN® Gel, 2% rather than 1% cream.
Contradictions
Low
AI Statement
Generic Naftifine is often sold as a 1% or 2% cream.
Label Reference
Provided label excerpt specifies NAFTIN® Gel is 2% (Section 3) and does not mention 1% or a cream formulation (Section 3).
Important Omissions
Indication specificity: the label states NAFTIN® Gel is indicated for interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum (Section 1).
Importance:
Moderate
Dosage/administration instructions: apply a thin layer once daily to affected areas plus ~1/2 inch margin for 2 weeks; topical use only and not for ophthalmic/oral/intravaginal use (Section 2).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Most claims are about availability/pricing/coupons not covered by the provided label excerpts; these do not directly state dosing or safety-critical contraindications. However, medical indication claims are non-specific and may be imprecise versus the label’s specific indication (interdigital tinea pedis due to specified organisms).
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Medical indication statements are overly broad (e.g., 'ringworm') relative to the label’s specific indication (interdigital tinea pedis due to specified organisms). Non-label claims about coupons/pricing/PBM discounts are not supported by the provided FDA label excerpts.
Suggested Improvement
Restrict indication language to the label’s exact indication (interdigital tinea pedis due to specified organisms) and omit pricing/discount/PBM/coupon availability claims unless supported by label content (or clearly label them as non-label, non-regulatory information). Include the label’s dosing and administration directions if making treatment-use claims.